2024-11-20 - Analysis Report
## Pfizer Inc. (PFE) Stock Analysis Report

**1. Performance Relative to S&P 500 (VOO):**

Pfizer Inc. (PFE) is a biopharmaceutical company that discovers, develops, manufactures, and markets biopharmaceutical products for a wide range of therapeutic areas.  The provided data shows a significant underperformance of PFE compared to the S&P 500 (VOO).  While VOO experienced a cumulative return of 125.6%, PFE registered a cumulative loss of -8.67%. This represents a considerable divergence of -134.27 percentage points.  The relative divergence of 0.03 indicates that PFE's performance is extremely low relative to its historical performance range against the S&P 500.

**2. Recent Price Movement:**

* **Closing Price:** $25.10
* **5-Day Moving Average:** $25.50
* **20-Day Moving Average:** $27.01
* **60-Day Moving Average:** $28.13

The price is currently below all three moving averages, suggesting a downtrend.

**3. Technical Indicators and Expected Return:**

* **RSI (21.82):**  Indicates the stock is in oversold territory, potentially suggesting a bounce.  However, it's important to note that oversold conditions can persist for extended periods.

* **PPO (-0.88):**  A negative PPO suggests bearish momentum.

* **Recent Relative Divergence (0.03, +):**  While showing a slight improvement over the past 20 days,  this needs to be viewed in the context of the larger negative trend.

* **Expected Return (0.0%):** The expected return of 0.0% indicates that based on current information, no significant return above the S&P 500 is anticipated over the long term (2+ years).  This should be considered cautiously, especially given the substantial underperformance against the benchmark index.  Long-term investment in PFE should involve careful monitoring of the company's performance and financial health.

* **Last Market Price (25.11):** Given that the market price is only slightly above the closing price there is no evidence of a significant market event that may influence the stock's price.

**4. Recent Earnings and Outlook:**

| Date        | EPS     | Expected EPS |
|-------------|---------|---------------|
| 2024-10-29 | 1.06    | 0.614         |
| 2024-07-30 | 0.60    | 0.458         |
| 2024-05-01 | 0.82    | 0.516         |
| 2024-01-30 | 0.10    | -0.19         |
| 2023-10-31 | -0.17   | -0.32         |


The most recent earnings (October 29, 2024) beat expectations, but overall, recent earnings have been mixed, and some quarters show significant discrepancies between actual and expected EPS.  Consistent performance is needed to reverse current negative trends.

**5. Financial Information:**

**1) Revenue and Profitability:**

| Quarter     | Revenue    | Profit Margin |
|-------------|------------|---------------|
| 2024-09-30 | $17.70B   | 70.27%        |
| 2024-06-30 | $13.28B   | 75.16%        |
| 2024-03-31 | $14.88B   | 77.29%        |
| 2023-12-31 | $14.25B   | 46.92%        |
| 2023-09-30 | $13.49B   | 31.30%        |

Revenue is relatively stable, but profit margins show significant fluctuations, raising concerns about consistency.

**2) Capital and Profitability:**

| Quarter     | Equity     | ROE           |
|-------------|------------|---------------|
| 2024-09-30 | $92.29B   | 4.84%         |
| 2024-06-30 | $87.70B   | 0.05%         |
| 2024-03-31 | $92.28B   | 3.38%         |
| 2023-12-31 | $89.01B   | -3.78%        |
| 2023-09-30 | $96.93B   | -2.46%        |

ROE has been volatile, indicating potential challenges in profitability and efficiency.


**7. News and Recent Issues:**

(This section requires access to real-time news sources like Shacknews and FINBOLD to provide a current analysis of recent earnings news, analyst opinions, and market outlook.  Please provide links to recent news articles for a complete analysis).


**8. Overall Analysis:**

PFE is currently significantly underperforming the S&P 500, showing a substantial negative cumulative return. While recent earnings beat expectations in the latest quarter, overall earnings have been mixed, and profit margins and ROE show inconsistency.  Technical indicators suggest oversold conditions but don't necessarily signal an imminent reversal.  The expected return is currently low, indicating that a long-term investment should be approached with caution and continuous monitoring of financial performance and market conditions.  Additional analysis of recent news and analyst opinions is necessary for a more comprehensive evaluation.


**9. Disclaimer:** This report is for informational purposes only and should not be considered financial advice.  Investment decisions should be made based on thorough research and consultation with a qualified financial advisor.  The information provided here is based on the data supplied and may not reflect the complete picture.
